{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:45:46Z","timestamp":1787013946021,"version":"build-2736575974"},"reference-count":21,"publisher":"Wiley","issue":"S3","license":[{"start":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T00:00:00Z","timestamp":1440720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2015,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      To characterise clinicopathological characteristics of prostate cancer among human immunodeficiency virus (\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      )\u2010positive men and to evaluate the current practice patterns in the management of prostate cancer in these men.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>\n                      We retrospectively reviewed all patients with\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      in the\n                      <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                      tate\u2010wide\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      referral centre in\n                      <jats:styled-content style=\"fixed-case\">V<\/jats:styled-content>\n                      ictoria, who were diagnosed with prostate cancer from 2000 onwards. In all, 12 patients were identified, and the medical records were reviewed to collect data on\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      parameters at the time of prostate cancer diagnosis, as well as prostate cancer clinicopathological characteristics, treatment details and outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At the time of prostate cancer diagnosis, eight patients had undetectable viral load, and the median cluster of differentiation 4 (\n                      <jats:styled-content style=\"fixed-case\">CD4<\/jats:styled-content>\n                      ) count was 485 cells\/\u03bcL. The average age at diagnosis of prostate cancer was 63 years and the median prostate\u2010specific antigen (\n                      <jats:styled-content style=\"fixed-case\">PSA<\/jats:styled-content>\n                      ) level of 11.1\u2009ng\/mL. Four patients had Gleason 6 prostate cancer, four Gleason 7, one Gleason 8 and three\n                      <jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>\n                      leason 9. Seven of the 12 patients had a positive family history for prostate cancer. Of the patients with clinically localised prostate cancer (10), most were treated with radiotherapy (\n                      <jats:styled-content style=\"fixed-case\">RT<\/jats:styled-content>\n                      ): one permanent seed brachytherapy (BT), five external beam\n                      <jats:styled-content style=\"fixed-case\">RT<\/jats:styled-content>\n                      (\n                      <jats:styled-content style=\"fixed-case\">EBRT<\/jats:styled-content>\n                      ), two open radical prostatectomies (RP), one active surveillance (AS), and one on watchful waiting (WW). For the two patients with metastatic disease, one had androgen\u2010deprivation therapy and\n                      <jats:styled-content style=\"fixed-case\">EBRT<\/jats:styled-content>\n                      , while the other had a combination of\n                      <jats:styled-content style=\"fixed-case\">EBRT<\/jats:styled-content>\n                      and chemo\u2010hormonal therapy with doxetacel. All patients were followed for a median of 46 months, with three deaths reported, none of which was a prostate cancer\u2010specific death.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This is the first\n                      <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>\n                      ustralasian series on prostate cancer management in a\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      population. With the prolonged survival among\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      \u2010positive men in the highly active anti\u2010retroviral therapy era,\n                      <jats:styled-content style=\"fixed-case\">PSA<\/jats:styled-content>\n                      testing should be offered to this group of patients, especially those with a positive family history.\n                      <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\n                      \u2010positive men should also be offered all treatment options in the same manner as men in the general population.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bju.13097","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T08:48:49Z","timestamp":1440751729000},"page":"5-10","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinicopathological characteristics and management of prostate cancer in the human immunodeficiency virus (\n                    <scp>HIV<\/scp>\n                    )\u2010positive population: experience in an\n                    <scp>A<\/scp>\n                    ustralian major\n                    <scp>HIV<\/scp>\n                    centre"],"prefix":"10.1111","volume":"116","author":[{"given":"Wee Loon","family":"Ong","sequence":"first","affiliation":[{"name":"Department of Urology Alfred Health  Melbourne Vic Australia"},{"name":"Departments of Epidemiology and Prevention Medicine Monash University  Melbourne Vic Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Manohar","sequence":"additional","affiliation":[{"name":"Department of Urology Alfred Health  Melbourne Vic Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Millar","sequence":"additional","affiliation":[{"name":"William Buckland Radiation Oncology Service Alfred Health  Melbourne Vic Australia"},{"name":"Departments of Epidemiology and Prevention Medicine Monash University  Melbourne Vic Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Royce","sequence":"additional","affiliation":[{"name":"Department of Urology Alfred Health  Melbourne Vic Australia"},{"name":"Surgery Monash University  Melbourne Vic Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,8,28]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-10-0741"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328331d384"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(95)96214-X"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61113-7"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2004.08.053"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2008.07474.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2006.06271.x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1308\/003588405X60696"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.3816\/CGC.2006.n.023"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2008.01.022"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1071\/SH07082"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2008.tb02048.x"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-009-0013-0"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja12.11241"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20389"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.21.1600"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.05.047"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-0614"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/13548506.2011.579989"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.10.028"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12764"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbju.13097","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.13097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:00:59Z","timestamp":1761739259000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/bju.13097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,28]]},"references-count":21,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["10.1111\/bju.13097"],"URL":"https:\/\/doi.org\/10.1111\/bju.13097","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,28]]},"assertion":[{"value":"2015-08-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}